CHANGELOG.md

Changelog

v0.1.3

• Expanded SEC-HPLC purity from 4 to 82 biosimilars, from the full supplier CoA vault (coa.ichor.bio), with lot numbers and concentrations.
• For 68 of them, recorded the exact monomer % read from the CoA chromatogram peak table (280 nm main peak), replacing the earlier ">95%" placeholder; the other 14 keep the CoA's

  95%/≥95% specification where no chromatogram is provided.

v0.1.2

• Added the first SEC-HPLC purity values from supplier Certificates of Analysis for 4 biosimilars (Selicrelumab, Farletuzumab, Bococizumab, Romosozumab).
• Added a SEC-HPLC method (M-SEC-HPLC) and filled lot number + concentration on sample rows.

v0.1.1

• Column and formatting cleanup of the antibodies table.
• Set expression_system to CHO for all antibodies.

v0.1.0

• Seed release: 480 antibodies with sequences + identity; 960 computed values (MW, theoretical pI).
• Structure established (Antibodies/Samples/Methods/Measurements + data dictionary).